US 12285496
Gene therapy for haploinsufficiency
granted A61KA61K38/17A61K48/0016
Quick answer
US patent 12285496 (Gene therapy for haploinsufficiency) held by The Regents of the University of California expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Apr 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K38/17, A61K48/0016, A61K48/0066, A61P